Frailty alone doesnt define liver transplant risk. Lai et al’s LT Comorbidity Index (LTCI) combines frailty with comorbidities to better predict outcomes and support objective selection.
A step toward data-driven transplant care!

👉 pubmed.ncbi.nlm.nih.gov/41537749/

@juanpabloarab.bsky.social

Phenomenal narrative review of SBP prophylaxis by @vinayjaha.bsky.social in @liverfellownetwork.bsky.social.

www.aasld.org/liver-fellow...

Discusses the literature, new and old, and the emerging antibiotic resistance. Certainly something to share with my trainees! @cwruim.bsky.social

Screening for MASLD by at 29th Annual Virginia Liver Symposium by @juanpabloarab.bsky.social @vculiver.bsky.social

🌎 prevalence of MASLD 30%
⬆️ risk progression with DM, HTN, obesity, menopause
Screen for 🍷
♻️ Putative connection between MASLD, CVD, CKD

Team VCU at AASLD MASLD/MetALD/ALD Emerging Topic Conference 2025, Las Vegas

@juanpabloarab.bsky.social @saulkarpen.bsky.social @vculiver.bsky.social

Thank you @aasldnews.bsky.social for the travel grant to present at #AASLDETC in ☀️ Las Vegas

Kudos to the organisers @juanpabloarab.bsky.social, Dr Noureddin and team!

#HepatologySky

Check out our recently published case report of ICI + CMV colitis, published in @amcollegegastro.bsky.social Case Reports Journal

pubmed.ncbi.nlm.nih.gov/39734389/

High-yield flowchart for management of ICIC included!

#GISky

A sweet start to 2025! Happy new year to the #LiverSky and #GISky squad 🥳

@amcollegegastro.bsky.social #VCUHealth

Congrats to inspiring investigators @anandvkulkarni.bsky.social @juanpabloarab.bsky.social and team, for late breaking abstract about rapid taper of steroids in AAH at #TLM24
⤵️ infections, hospitalizations with rapid taper
💫 changing practice in management of AAH
#LiverSky #AASLD

Happy to share our findings about naltrexone in decompensated cirrhosis, at #TLM2024.
Grateful for the support of my mentors Dr Devuni, @juanpabloarab.bsky.social, and my excellent co-author Dr Cooper! #LiverSky